Current treatment options to prevent perinatal transmission of HIV

Bibliography

• UNLINKED ANONYMOUS SURVEYS STEERING GROUP: Prevalence of HIV in England and Wales in 1997. Annual Report of the Unlinked Anonymous Prevalence Monitoring Programme. Department of Health, London, UK (1997).
   Google Scholar
• PECKHAM CS, GIBB D: Mother-to-child transmission of the human immunodeficiency virus. N Engl. J. Med. (1995) 333(5)298–302.
   Google Scholar
• NEWELL M-L, GRAY G, BRYSON YJ: Prevention of mother-to-child transmission of 11IV-1 infection. AIDS (1997) 11 (Suppl. A):S165–172.
   Google Scholar
• CONNOR EM, SPERLING RS, GELBER R et al: Reduction of maternal-infant transmission of human immunodefi-ciency virus Type 1 with zidovudine treatment. N Engl. J. Med. (1994) 33i(18):1173–1180
   Google Scholar
• MOFENSON LM, STEIHN ER, LAMBERT JS eta].: Efficacy ofzidovudine (ZDV) in reducing perinatal 11IV-1 transmission in 11IV-1 infected women with advanced disease. Proceedings of the 37th Intel-sciences Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada (1997). Abstract 1–117.
   Google Scholar
• MOFENSON LM, LAMBERT JS, STEIHN ER et al: Riskfactors for perinatal transmission of human immuno-deficiency virus Type 1 in women treated with zidovu-dine. N Engl. J. Med. (1999) 34i(6):385–93.
   Google Scholar
• SHAFFER N, CHUACHOOWANG R, MOCK PA et al.: Short course zidovudine for perinatal 11IV-1 transmission in Bangkok: a randomised controlled trial. Lancet (1999) 353(9155)773–780.
   Google Scholar
• DABIS F, MSELLARI P, MEDA N et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double blind placebo-controlled multicentre trial. Lancet (1999) 353 (9155) 786–792
   PubMed Web of Science ®Google Scholar
• WIKTOR SZ, EKPINI E, KAREN JM etal. Short-course oral zidovudine for prevention of mother-to-child transmission of 11IV-1 in Abidjan, Clite d'Ivoire: a randomised trial. Lancet (1999) 353 (9155) 781–785
   Google Scholar
• GUAY LA, MUSOKE P, FLEMING T et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of 11IV-1 in Kampala, Vganda - HIVNET 012 randomised trial. Lancet (1999) 354(9181):795–802.
   PubMed Web of Science ®Google Scholar
• JOHNSON MA, GOODWIN C, YUEN GJ et al.: The pharmacokinetics of 3TC administered to 11IV-1 infected women (pre-partum, during labour and post-partum) and their offspring. XI International Conference on AIDS. Vancouver, Canada (7–12 July 1996) 249–250. Abstract Tu.C445.
   Google Scholar
• MOODLEY J, MOODLEY D, PILLAY K et al.: Antiviral effect of lamivudine alone and in combination with zidovudine in HIV infected pregnant women. Program and Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, USA (22–26 January 1997) 176. Abstract 607.
   Google Scholar
• MIROCHNICK M, SULLIVAN J, GAGNLER P et al.: Safety and pharmacokinetics (PK) of nevirapine (NVP) in neonates born to 11IV-1 infected women. Program and Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, USA (22–26 January 1997) 176. Abstract 723.
   Google Scholar
• CASEY BM, BAWDON RE: Placental transfer of ritonavir with zidovudine in the ex vivo placental transfer model. Am. J. Obst. Gynecol. (1998) 179(3 Pt1):758–761.
   Google Scholar
• BAWDON RE: The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir. Infect. Dis. Obstet. Gynecol. (1998) 6(6):244–246.
   PubMedGoogle Scholar
• SABA J: UNAIDS [Symposium Lecture S7]. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, USA (31 January - 4 February 1999).
   Google Scholar
• French Cohort Study Group [Presentation]. 6th Confer-ence on Retroviruses and Opportunistic Infections. Chicago, USA (31 January - 4 February 1999).
   Google Scholar
• BLANCHE S, TARDLIEU M, RUSTIN P et al: Persistant mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 354(91801084–1089.
   Google Scholar
• TAYLOR GP, LYALL EGH, MERCEY D et al: British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm. Infect. (1999) 75:90–97
   PubMedGoogle Scholar
• MINKOFF H, AUGENBAUN M: Antiretroviral therapy for pregnant women. Am. J. Obstet. Gynecol (1997) 176(2):478–489.
   PubMedGoogle Scholar
• SILVERMAN NS, WATTS DH, HITTI J et al.: Initial multicentre experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy. Infect. Dis. Obstet. Gynecol. (1998) 6(6)237–243.
   Google Scholar
• MIROCHNICK M, FENTON T, GAGIER P et al.: Pharmacokinetics of nevirapine in human immuno-deficiency virus Type 1-infected pregnant women and their neonates. J. Infect. Dis. (1998) 178(2):368–374.
   PubMed Web of Science ®Google Scholar
• Paediatric AIDS Clinical trials Group Protocol 382, Version 2.0 (26 May 1998).
   Google Scholar
• LORENZI P, MASSEREI V, LAUBEREAU B et al.: Safety of combined antiretroviral therapies with or without protease inhibitors in pregnant HIV-infected women and their off-spring. XII International conference on AIDS. Geneva, Switzerland (28 June - 3 July 1998). Abstract 32453.
   Google Scholar
• THE EUROPEAN MODE OF DELIVERY COLLABORATION: Elective caesarean-section versus vaginal delivery in prevention of vertical 11IV-1 transmission: a random-ised clinical trial. Lancet (1999) 353(9158):1035–1039.
   PubMedGoogle Scholar
• THE INTERNATIONAL PERINATAL HIV GROUP: Mode of delivery and vertical transmission of 11IV-1: a meta-analysis from fifteen prospective cohort studies. N Engl. J. Med. (1999) 340(13):977.
   PubMed Web of Science ®Google Scholar
• CENTERS FOR DISEASE CONTROL: Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-98. MMWR Morb. Mortal Wkly Rep. (1998) 47:151–154.
   PubMedGoogle Scholar
• UNAIDS: HIV and infant feeding. A review of HIVtransmission through breastfeeding. UNAIDS/WHO Joint United Nations Programme on HIV/AIDS (UNAIDS). WHO, Geneva, Switzerland (June 1998).
   Google Scholar
• DUNN DT, NEWELL M-L: Risk of human immunodefi-ciency virus type-1 transmission through breast-feeding. Lancet (1992) 340(8819)585–588.
   Google Scholar
• TESS BH, RODRIGUES RC, NEWELL ML et al.: Infantfeeding and risk of mother-to child transmission of 11IV-1 in Sao Paola State, Brazil. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol (1998) i9(2):189–194.
   Google Scholar
• LEROY V, NEWELL M-L, DABIS F et al.: International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet (1998) 352(9128):597–600.
   PubMedGoogle Scholar
• COUTSOUDIS A, PILLAY K, SPOONER E: Influence of infant feeding patterns on early mother-to-child transmission of 11IV-1 in Durban, South Africa: a prospective cohort study. Lancet (1999) 354 (9177):471–476.
   PubMed Web of Science ®Google Scholar
• BRECKENRIDGE A: Antiretroviral drugs to reduce vertical transmission of HIV infection. GEM/CMG/99/5 (25 June 1999) [Communication].
   Google Scholar
• http: //www.who. int/emc/diseases/HIV/indexl. html WHO/UNAIDS: AIDS epidemic update. (1998).
   Google Scholar
• http://www.niaid.nih.gov/newsroom/HIV012.htm JACKSON B, FLEMING TR: A Phase 003 randomised controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda. National Institute of Allergy and Infectious Diseases (1999).
   Google Scholar
• http://www.medscape.com/medscape/HIV/ClinicalMgmt/ CM.v09/public/index-CM.v09.html LEVINE A: HIV disease in women. HIV Clinical Management (1998) 9.
   Google Scholar
• http://www.medscape.com/medscape/HIV/journa1/1999/v 05..../pnt-mha0622.13.boye.htm BOYER P: Family planning for HIV-infected persons. Medscape HIV/AIDS Annual Update (1999) 5 (Suppl.).
   Google Scholar